Paris, France, – Cellectis (Alternext: ALCLS), the genome engineering specialist, announces that it has signed two exclusive license agreements with the Iowa State University that grant Cellectis the worldwide right to use inventions related to TAL effector-nucleases (TALENsTM) and monomeric TALENsTM . These two exclusive licenses granted to Cellectis cover all uses of the TAL […]
MADISON, WIS., Oct. 24, 2012 – The National Institutes of Health Center for Regenerative Medicine (NIH-CRM) has awarded Cellular Dynamics International, Inc. (CDI), the world’s largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, a contract to provide human iPS cell lines and terminally differentiated tissue cells from normal or […]
With more than 20 years of experience in RNA isolation, AMSBIO has generated over 4000 individual total RNAs ready to go off-the-shelf, many with bioanalyser RIN scores to demonstrate their high quality. Isolated from a variety of tissues – the AMSBIO biorepository of RNA samples covers over 30 species including human, animal, plant, insect and […]
Cambridge, Massachusetts (United States) – Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), announces that it has been awarded a second contract to provide services to the National Institutes of Health (NIH) and certain other government agencies. This multiple award, indefinite delivery/indefinite quantity (IDIQ) contract, has a maximum order […]
Bioo Scientific, a world leader and innovator in the life science industry, is raising the bar for delivering nucleic acids with the release of NextFect 2012, the “Next Generation Transfection Agent”. NextFect 2012 can be used in both cell culture and in animal systems, thereby streamlining the processes of understanding cellular activity in vitro, and […]
MOUNTAIN VIEW, Calif., — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., is honored to receive the RUSNANOPRIZE 2012 together with Dr. Sergey Lukyanov, for the innovation “Fluorescent proteins of coral polyps: discovery and use in biotechnology”. The RUSNANOPRIZE is a major international award for nanotechnology discoveries and innovations that was established by […]
In compliance with ASX Continuous Disclosure Rules, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report it has executed a Covenant Not To Sue And Release Agreement with One Lambda Inc. (“One Lambda”) of Canoga Park, California, USA. The precise commercial terms of the Agreement are covered by formal confidentiality provisions and cannot […]
Madison, WI USA: Promega Corporation announced today that it has launched GoTaq® Probe PCR Master Mix, GoTaq Probe 1-Step RT-qPCR System, and GoTaq Probe 2-Step RT-qPCR System. These ready-to-use, 2x master mixes simplify the preparation of reactions for qPCR using hydrolysis probe detection, and are designed for sensitive sequence detection and quantification over a broad […]
BERLIN, –caprotec bioanalytics GmbH announced today a restructuring of its senior management and the appointment of Dr. Jonathan Turner as Managing Director and Chief Executive Officer. Dr. Turner joins caprotec as a highly regarded pharmaceutical executive and has held a number of senior management positions at global pharmaceutical companies, including Boehringer Ingelheim, AstraZeneca PLC and […]
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced that Takara Bio Inc. will take over the distribution of miRCURY LNA™ products in Asia. Takara Bio Inc. will market Exiqon’s life sciences products in Japan, China, Hong Kong, South Korea and India. Takara Bio Inc. is a leading […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
